LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872104. A total of 102 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 1.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 29,782,609 | $64,628,000 | 99.85% |
| Artal Group S.A. | 253,372,135 | $549,818,000 | 17.30% |
| NEA Management Company, LLC | 11,676,000 | $25,337,000 | 1.13% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 250,000 | $543,000 | 0.39% |
| WILLIAM HARRIS INVESTORS INC | 204,342 | $443,000 | 0.14% |
| HOWARD HUGHES MEDICAL INSTITUTE | 136,528 | $296,000 | 0.10% |
| Southeast Asset Advisors Inc. | 66,555 | $144,000 | 0.07% |
| SMITH ASSET MANAGEMENT GROUP LP | 535,455 | $1,162,000 | 0.05% |
| Teton Advisors, Inc. | 230,000 | $499,000 | 0.04% |
| USCA RIA LLC | 40,000 | $87,000 | 0.04% |